Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews.

BMC Cardiovasc Disord · 2020 · PMC7164287 · PMID 32303191

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

All the results failed to reach statistical significance, aliskiren showed no difference three drugs.

also in 6,035 other papers

did not reach statistical significanceno p-value reported

The results showed aliskiren had renoprotective influence and led to fewer renal impairment events, though this did not reach statistical significance (RR 0.97,0.81 to 1.16) [ 21 ] (see Table 6 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.